MustGrow Biologics Balance Sheet Health
Financial Health criteria checks 6/6
MustGrow Biologics has a total shareholder equity of CA$5.6M and total debt of CA$759.3K, which brings its debt-to-equity ratio to 13.6%. Its total assets and total liabilities are CA$6.9M and CA$1.4M respectively.
Key information
13.6%
Debt to equity ratio
CA$759.33k
Debt
Interest coverage ratio | n/a |
Cash | CA$6.82m |
Equity | CA$5.58m |
Total liabilities | CA$1.35m |
Total assets | CA$6.94m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MGRO's short term assets (CA$6.9M) exceed its short term liabilities (CA$1.2M).
Long Term Liabilities: MGRO's short term assets (CA$6.9M) exceed its long term liabilities (CA$140.9K).
Debt to Equity History and Analysis
Debt Level: MGRO has more cash than its total debt.
Reducing Debt: MGRO had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MGRO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MGRO has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 22.9% each year